Showing results (121-130 of 284) with videos related to

Sort By:
Pageof 29
Molecular Microbiology|January 22, 2005
Cell division in cocci: localization and properties of the Streptococcus pneumoniae FtsA proteinBeatriz Lara, Ana Isabel Rico, Sabrina Petruzzelli, et al.
Sports Medicine - Open|October 20, 2015
Influence of the MCT1 rs1049434 on Indirect Muscle Disorders/Injuries in Elite Football PlayersMyosotis Massidda, Nir Eynon, Valeria Bachis, et al.
Anticancer Research|August 15, 2002
A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancerS Tomao, A Romiti, B Massidda, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1990
Neoadjuvant chemotherapy with cisplatinum and 5-fluorouracil in advanced head and neck cancerG Teatini, F Meloni, M Bisail, et al.
Clinical & Developmental Immunology|January 4, 2011
Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazoleDavide Firinu, Orietta Massidda, Maria Maddalena Lorrai, et al.
Proteins|December 18, 2002
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsADaniele Carettoni, Paulino Gómez-Puertas, Lucía Yim, et al.
Anti-Cancer Drugs|August 31, 2006
Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancerPasquale Comella, Bruno Massidda, Sergio Palmeri, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|November 6, 2014
[Discriminating capacity of the MASI-R questionnaire in the perception of work-stress]Ines Giorgi, Paolo Mainetti, Elena Fiabane, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Mechanical Rejuvenation of Mesenchymal Stem Cells from Aged PatientsMiles W Massidda, Andrei Demkov, Aidan Sices, et al.
Lung Cancer (Amsterdam, Netherlands)|February 15, 2007
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trialPasquale Comella, Carlo Putzu, Bruno Massidda, et al.
Pageof 29